Home > Insider Trading > Filing (0001593968-22-000496)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1771917	Karuna Therapeutics Inc.	KRTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579829	A. Troy Ignelzi	C/O Karuna Therapeutics, Inc. 99 High Street, 26Th Floor Boston MA 02110	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-02-15	1,500	$9.20	26,470	No	4	M	Direct
Common Stock	Disposition	2022-02-15	1,500	$111.14	24,970	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Option (right to buy)	Disposition	2022-02-15	1,500	$0.00	1,500	$9.20
Common Stock	Option (right to buy)	Acquisiton	2022-02-16	48,500	$0.00	48,500	$111.97

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
158,856		2029-03-21	No	4	M	Direct
48,500		2032-02-15	No	4	A	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2022.
This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2019, with additional vesting as to 12.5% of the shares underlying the option award on each six month period thereafter.
25% of the options shall vest on February 16, 2023, and the remaining options shall vest in twelve equal three-month installments over the following three years, subject to continued service through such dates.